Back to the main directory
Press Release
- CTO Realty Growth Announces Third Quarter 2023 Earnings Release and Conference Call Information by GlobeNewsWire
- Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023 by GlobeNewsWire
- Abeona Therapeutics Submits Biologics License Application to U.S. FDA Seeking Priority Review and Approval of EB-101 for the Treatment of Patients with Recessive Dystrophic Epidermolysis Bullosa by GlobeNewsWire
- Theratechnologies présente ses résultats financiers pour le troisième trimestre et les neuf premiers mois de l’exercice 2023 et fait le point sur ses activités commerciales by GlobeNewsWire
- Aehr Test Systems to Announce First Quarter Fiscal 2024 Financial Results on October 5, 2023 by GlobeNewsWire
- Syneos Health Names Terttu Haring President, Clinical Sites & Patients by GlobeNewsWire
- Inozyme Pharma Announces Positive Interim Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) by GlobeNewsWire
- Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conference by Newsfile Corp.
- EQS-News: Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases by EQS Group AG
- Leading Industry Energy Research Association Chooses Draganfly Commander 3XL Platform for Inspection Standards Operations by GlobeNewsWire
- Sitio Royalties Announces $500 Million Offering of Senior Notes by BusinessWire
- Armanino Foods of Distinction, Inc. Maintains Its Regular Quarterly Dividend of $.033 Per Share by BusinessWire
- Kahtlustus Iru elektrijaama kahe töötaja suhtes by GlobeNewsWire
- Registration Is Now Open For Tribe Public’s Webinar Event "Immunotherapy Reimagined" Featuring Indaptus Therapeutics’ CEO On Friday, September 29, 2023 by GlobeNewsWire
- Motomova Inc. to Present at the 8th Annual Dawson James Conference by GlobeNewsWire
- WillScot Mobile Mini to Participate in Deutsche Bank Leveraged Finance Conference by GlobeNewsWire
- Galectin Therapeutics to Present Update on its Belapectin Liver Cirrhosis Program at the 20th Edition of Discovery on Target meeting, in Boston, September 25-28, 2023 by GlobeNewsWire
- Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego by GlobeNewsWire
- Taysha Gene Therapies Announces Second Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Adult Trial for the Treatment of Rett Syndrome by GlobeNewsWire
- Massive, multi-year transformation of Verizon’s network yields major benefits for customers by GlobeNewsWire
- Infinera and Sumitomo Electric First to Demonstrate High-speed Business Services over 10G-EPON Infrastructure with ICE-X Coherent Pluggable Optics by GlobeNewsWire
- New “Test Force” campaign from Verizon captures company’s relentless drive for network excellence by GlobeNewsWire
- OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform by GlobeNewsWire
- BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma by GlobeNewsWire
- Outbrain and DoubleVerify Partner to Enhance Onyx Campaigns for Brand Advertisers by GlobeNewsWire